Atara Biotherapeutics, Inc. (ATRA)

Biological Products, (No Diagnostic Substances)

Latest Price

$8.17

TTM P/E

Normalized P/E

Div Yield

Book Value

0.07

P/B Ratio

114.59

Valuation metrics

EPS: $2.57

Target P/E: 15×

Formula: EPS × P/E

P/E Fair Value

$38.55

+372% upside

28.5% held by institutions

Institution	Shares	Value	Ownership %	Change	Filing Date
ADAGE CAPITAL PARTNERS GP, L.L.C.	700.0K	$3.0M	8.22%	--	2026-03-31
Redmile Group, LLC	441.7K	$2.0M	5.19%	--	2026-03-31
MACKENZIE FINANCIAL CORP	313.6K	$1.0M	3.68%	+255.0K	2026-03-31
VANGUARD CAPITAL MANAGEMENT LLC	217.9K	$1.0M	2.56%	--	2026-03-31
Point72 Asset Management, L.P.	194.3K	--	2.28%	+176.0K	2026-03-31
EcoR1 Capital, LLC	99.6K	--	1.17%	-473.6K	2026-03-31
BlackRock, Inc.	79.0K	--	0.93%	+11.9K	2026-03-31
GEODE CAPITAL MANAGEMENT, LLC	66.1K	--	0.78%	+3.8K	2026-03-31
UBS Group AG	50.1K	--	0.59%	+48.7K	2026-03-31
STALEY CAPITAL ADVISERS INC	50.0K	--	0.59%	--	2026-03-31